Latest Production News

Vulcan Energy has awarded a €72 million EPCM contract to a Sedgman and HOCHTIEF joint venture for its Phase One Lionheart Project, aiming to produce 24,000 tonnes of lithium hydroxide annually to fuel half a million electric vehicles.

Talga Group has applied for a SEK 1.1 billion grant to fund a commercial-scale battery anode plant in Sweden, complementing existing EU funding and securing strong customer interest.

Sunrise Energy Metals has raised A$18.865 million through a premium-priced share placement to fast-track pre-construction at its Syerston Scandium Project, reinforcing its path toward becoming a primary scandium supplier.

Dateline Resources reports robust gold intercepts from recent drilling at its Colosseum Gold-REE Project in California, exceeding current resource grades and supporting an updated mineral resource estimate and ongoing feasibility study.

Koba Resources has reported exceptionally high tin grades up to 21.3% from initial sampling at its Mt Garnet Tin-Tungsten Project, Queensland, confirming a large, underexplored soil anomaly and advancing plans for drilling in early 2026.

Jindalee Lithium has completed its 2025 drilling program at the McDermitt Lithium Project and is advancing plans to list its US subsidiary on a national exchange, extending exclusivity with its merger partner.

Polymetals Resources has raised $34.4 million through a share placement to boost exploration and production at its Endeavor Silver Zinc Mine, attracting strong institutional demand.

Nexsen Limited has appointed internationally acclaimed surgeon-scientist Professor Shekhar Kumta to its board, aiming to fast-track clinical validation and regulatory approval for its rapid diagnostic platforms ahead of a planned 2026 market entry.

Prairie Lithium has completed critical groundwork at its Canadian lithium brine project, setting the stage for construction and commercial operations in 2026 amid rising lithium prices.

Microba Life Sciences has secured a $3.06 million R&D tax incentive refund for FY25, reinforcing its cash reserves and supporting ongoing advancements in gastrointestinal diagnostics and clinical therapeutics.

Phoslock Environmental Technologies is set to resume production at its Changxing factory after a four-year halt, signaling renewed confidence in market demand and operational stability.

Invion Limited has expanded its global rights to the Photosoft™ technology, gaining exclusive perpetual licenses across a broad range of human and animal diseases, including cancers and infectious diseases. This milestone-based deal positions Invion to accelerate clinical development and commercialisation worldwide.